✦ LIBER ✦

Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration

✍ Scribed by Philip J. Rosenfeld; Steven D. Schwartz; Mark S. Blumenkranz; Joan W. Miller; Julia A. Haller; James D. Reimann; William L. Greene; Naveed Shams

Book ID: 116803489
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 225 KB
Volume: 112
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2005.01.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of cataract surgery in patients

Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy

✍ Homayoun Tabandeh; Nauman A. Chaudhry; David S. Boyer; Veronica A. Kon-Jara; Har 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Anti–Vascular Endothelial Growth Factor

Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration: A Report by the American Academy of Ophthalmology

✍ Michael S. Ip; Ingrid U. Scott; Gary C. Brown; Melissa M. Brown; Allen C. Ho; Su 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 148 KB